Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells☆
Section snippets
Experimental procedures
Materials. Antibodies against EGFR, phospho-specific antibodies against Tyr1068-phosphorylated EGFR, and phospho- and non-specific antibodies to ERK1/2 were purchased from Santa Cruz Biotechnology (Santa Cruz). EGFR-neutralizing antibody (Clone 225) was purchased from Lab Vision Corporation. Amphiregulin- and HB–EGF-neutralizing antibodies were purchased from R&D. TGFα-neutralizing antibody was purchased from BioVision. Antibodies against ADAM10 and ADAM17 were purchased from AnaSpec Inc.
DC-induced ERK1/2 activation in AGS cells
DC induces a rapid activation of ERK1/2 in many different cell systems including liver [4], biliary [5], and gastric cells [6]. Consistent with previous findings, treatment of AGS cells with DC-induced phosphorylation of ERK-1/2 MAPK within 5 min that was detectable for at least 2 h (Fig. 1a).
DC activation of EGFR in AGS cells is ligand-dependent
Previous studies have implicated EGFR activation in bile acid-mediated activation of ERK1/2 in hepatocytes and cholangiocytes [4], [5]. We tested whether EGFR was also involved in the DC-induced activation
Discussion
We report that EGFR–ERK1/2 pathways are activated in AGS cells treated with DC. Our results suggest that the novel GPC receptor M-BAR functions in the transactivation event, and that transactivation of EGFR, specifically, occurs via an ADAM/HB–EGF dependent pathway. Our results provide new insights that may contribute to the development of therapeutic tools to treat or prevent gastrointestinal neoplasm.
Data from many reports make it clear that the EGF receptor functions within signaling
Acknowledgment
We thank Ms. Y. Okayama for excellent technical assistance.
References (29)
- et al.
Dihydroxy bile acids activate the transcription of cyclooxygenase-2
J. Biol. Chem.
(1998) - et al.
G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor
J. Biol. Chem.
(2005) - et al.
ADAM-mediated ectodomain shedding of HB–EGF in receptor cross-talk
Biochim. Biophys. Acta
(2005) - et al.
Identification of membrane-type receptor for bile acids (M-BAR)
Biochem. Biophys. Res. Commun.
(2002) - et al.
J. Biol. Chem.
(2003) - et al.
Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation
Biochem. Biophys. Res. Commun.
(2002) - et al.
The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced from signaling cascades
J. Biol. Chem.
(2003) - et al.
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors
Biochem. Pharmacol.
(2005) - et al.
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
Biochem. Biophys. Res. Commun.
(2005) - et al.
Colorectal Cancer-Molecular Mechanisms, Premalignant State and Its Prevention
(1999)
Stomach cancer after partial gastrectomy for benign ulcer disease
N. Engl. J. Med.
Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats
Int. J. Cancer
Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis
Mol. Biol. Cell
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
Am. J. Physiol.
Cited by (0)
- ☆
This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan to H.Y.